Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy

Obstetrics and Gynecology

Volumn 78, Issue 1, 1991, Pages 128-135

  Hanssens, Myriam ^a,b   Keirse, Marc J N C ^a,b   Vankelecom, Frieda ^a,b   van Assche, F André ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; ENALAPRIL;

ADULT; CONTROLLED STUDY; FEMALE; FETUS MALFORMATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FETAL DEATH; HUMAN; INFANT MORTALITY; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0025910764     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Ondetti MA, Rubin B, Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977;196:441–4.
2. Ferguson RK, Turini GA, Brunner HR, Gavras H, Mc Kinstry D. A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet 1977;i:775–8.
3. Patchett AA, Harris H, Tristam EW, et al. A new class of angiotensin converting enzyme inhibitors. Nature 1980;288:280–3.
4. Johnston CI. Angiotensin converting enzyme inhibitors. In: Doyle AE, ed. Clinical pharmacology of hypertensive drugs. Amsterdam: Elsevier, 1984:272–311. (Birkenhäger WH, Reid JL. Handbook of hypertension; vol 5.)
5. Lund-Johansen P. Hemodynamic effects of antihypertensive agents. In: Doyle AE, ed. Clinical pharmacology of hypertensive drugs. Amsterdam: Elsevier, 1984:39–66. (Birkenhäger WH, Reid JL. Handbook of hypertension; vol 5.)
6. Broughton-Pipkin F, Symonds EM, Turner SR. The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol 1982,323:415–22.
7. Keith IM, Will JA, Weir EK. Captopril: Association with fetal death and pulmonary vascular changes in the rabbit (41446). Proc Soc Exp Biol Med 1982;170:378–83.
8. Broughton-Pipkin F, Wallace CP. The effect of enalapril (MK 421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus. Br J Pharmacol 1986;87:533–42.
9. Hurault de Ligny B, Mintz Ph, Ryckelynck JPh, Herlicoviez M, Muller G, Lévy G. Traitement par captopril de l’hypertension artérielle sévère au cours de la grossesse. J Gynécol Obstét Biol Reprod 1987;16:643–8.
10. Schubiger G, Flury G, Nussberger J. Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate. Brief report. Ann Intern Med 1988;108:215–6.
11. Kloosterman GJ. On intrauterine growth. Int J Gynaecol Obstet 1970;8:895–912.
12. Millar JA, Wilson PD, Morrison N. Management of severe hypertension in pregnancy by a combined drug regimen including captopril: Case report. N Z Med J 1983;96:796–8.
13. Rothberg AD, Lorenz R. Can captopril cause fetal and neonatal renal failure? Pediatr Pharmacol 1984;4:189–92.
14. Coen G, Cugini P, Gerlini G, Finistauri D, Cinotti GA. Successful treatment of long-lasting severe hypertension with captopril during a twin pregnancy. Nephron 1985;40:498–500.
15. Plouin PF, Tchobroutsky C. Inhibition de l’enzyme de conversion de I’angiotensine au cours de la grossesse humaine. Presse Méd 1985;14:2175–8.
16. Mochizuke M, Maruo T, Motoyama S. Treatment of hypertension in pregnancy by a combined drug regimen including captopril. Clin Exp Hypertens Hypertens Pregn 1986;B5:69–78.
17. Kaler SG, Patrinos ME, Lambert GH, Myers TF, Karlman R, Anderson CL. Hypertrichosis and congenital anomalies associated with maternal use of minoxidil. Pediatrics 1987;79:434–6.
18. Kreft-Jais C, Plouin PF, Tchobroutsky C, Boutroy MJ. Angiotensin-converting enzyme inhibitors during pregnancy: A survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol 1988;95:420–2.
19. Owen J, Hauth JC. Polyarteritis nodosa in pregnancy: A case report and brief literature review. Am J Obstet Gynaecol 1989;160:606–7.
20. Svensson A, Andersch B, Dahlof B. ACE-hämmare i samband med graviditet kan medföra risker for fostret. Lakartidningen 1986;83:699–700.
21. Rosa FW, Bosco LA, Graham CF, Milstien JB, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 1989;74:371–4.
22. Scott AA, Purohit DM. Neonatal renal failure: A complication of maternal antihypertensive therapy. Am J Obstet Gynecol 1989; 160:1223–4.
23. Baethge BA, Wolf RE. Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using converting enzyme inhibitors. Ann Rheum Dis 1989;48:776–8.
24. Katz AI, Davison JM, Hayslett JP, Singson E, Lindheimer MD. Pregnancy in women with kidney disease. Kidney Int 1980;18:192–206.
25. Redman CWG, Beilin LJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;ii;753–6.
26. Wildschut HIJ, Treffers PE, Hart AAM. The effect of hypertension on fetal growth. Clin Exp Hypertens Hypertens Pregn 1983;B2:43–7.
27. Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. Br J Obstet Gynaecol 1980;87:13–8.
28. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:11–25.
29. Ellison RC, Peckham GJ, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71:364–72.
30. Gouyon JB, Guignard JP. Insuffisance rénale vasomotrice du nouveau-né. Physiopathologie et traitement. Arch Fr Pediatr 1989;46:137–41.
31. Rudolph AM, Heymann MA, Teramo KAW, Barrett CT, Räihä NCR. Study on the circulation of the previable human fetus. Pediatr Res 1971;5:452–65.
32. Blythe WB. Captopril and renal autoregulation. N Engl J Med 1983;308:390–1.
33. Packer M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847–53.
34. Collins R, Wallenburg HCS. Pharmacological prevention and treatment of hypertensive disorders in pregnancy. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989:512–33.